-
Reviews
Back to Reviews
Submited on: 12 Dec 2011 08:41:20 AM GMT
Published on: 13 Dec 2011 03:35:49 PM GMT
-
Other Comments:
It is a well done and interesting manuscript.
-
Competing interests:
No
-
Invited by the author to review this article? :
No -
Have you previously published on this or a similar topic?:
No
-
References:
None -
Experience and credentials in the specific area of science:
I attend bisphosphonate patients in my Oral and Maxillofacial Diagnosis Clinic.
- How to cite: Ledesma-Montes C .Comment on Bisphosphonates manuscript[Review of the article 'Bisphosphonate-induced Jaw Osteonecrosis (BJON) & its Management Strategy ' by Dayma V].WebmedCentral 2014;3(4):WMCRW001736
The author's aim is to provide clinical recommendations on prevention and management of individuals who have beem administered bisphosphonates intravenously.
Yes
Yes
Yes
No
Yes
No
Yes- it would be a very nice lecture for all dentists.
Bisphosphonate-induced jaw osteonecrosis (BJON) is highly associated with two intravenous bisphosphonate formulations. Dentists need to be aware of the possibility of BJON which can occur spontaneously or after any dentoalveolar procedure in the population at risk. Early referral to the proper specialist is paramount once BJON is suspected.
None
No
No
None
Clinical associate professor